Sebagai perpustakaan, NLM menyediakan akses terhadap literatur ilmiah.

Dimasukkannya database NLM tidak berarti dukungan atau persetujuan terhadap

konten NLM atau Institut Kesehatan Nasional.
Pelajari lebih lanjut: Penafian PMC | Pemberitahuan Hak Cipta PMC

J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. Naskah penulis; PMCID: PMC6349368
tersedia di PMC 2019 28 Januari. NIHMSID: NIHMS1001951
Diterbitkan dalam bentuk editan akhir sebagai: PMID: 26986231
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2016 2 April;
34(2): 77–96.
doi: 10.1080/10590501.2016.1166826

Aloe vera : Tinjauan toksisitas dan efek klinis yang merugikan

Xiaoqing Guo dan Nan Mei

Abstrak

Tanaman lidah buaya digunakan sebagai suplemen makanan dalam berbagai makanan dan
sebagai bahan produk kosmetik. Paparan yang meluas pada manusia serta potensi aktivitas
beracun dan karsinogeniknya meningkatkan kekhawatiran akan keselamatan. Analisis kimia
mengungkapkan bahwa tanaman lidah buaya mengandung berbagai polisakarida dan bahan
kimia fenolik, terutama antrakuinon. Menelan sediaan lidah buaya dikaitkan dengan diare,
hipokalemia, pseudomelanosis coli, gagal ginjal, serta fototoksisitas dan reaksi hipersensitif.
Baru-baru ini, ekstrak daun lidah buaya utuh menunjukkan bukti jelas adanya aktivitas
karsinogenik pada tikus, dan diklasifikasikan oleh Badan Internasional untuk Penelitian
Kanker sebagai kemungkinan karsinogen bagi manusia (Kelompok 2B). Tinjauan ini
menyajikan informasi terkini mengenai efek toksikologi, termasuk sitotoksisitas,
genotoksisitas, karsinogenisitas, dan efek klinis yang merugikan dari ekstrak daun lidah
buaya utuh, gel, dan lateks.
Kata kunci: Gel lidah buaya, lateks lidah buaya, Lidah buaya , karsinogenisitas,
genotoksisitas, efek toksikologi

1. Perkenalan

The use of herbal products has been growing rapidly in the general population. In 2007, the
National Health Interview Survey reported that approximately 40% of Americans, including
adults and children, used complementary and alternative medicine as alternative therapy in
the past 12 months.[1] About US $14.8 billion was spent on the purchase of nonvitamin,
nonmineral natural products, which accounted for 44% of all out-of-pocket costs for
complementary and alternative medicine.[2] Aloe has enjoyed a long history of providing a
myriad of health benefits, and is one of the most frequently used herbal remedies employed
throughout the world. There are more than 400 species of Aloe, but the most popular and
widely used species is Aloe barbadensis Miller (also called Aloe vera Linne, commonly
referred to Aloe vera). Aloe is derived from the Arabic word alloeh meaning “bitter and
shiny substance,” and vera from the Latin word for “truth.” Other species used in health and
medicine include but are not limited to Aloe arborescens Miller (a member of the
asphodelacea family), Aloeperryi Baker, Aloe andongensis, and Aloe ferox.[3,4]

Aloe vera, a genus within the Liliaceae family, is a stemless or very short-stemmed perennial
succulent or xerophyte with elongated and peaked leaves in which large amounts of water are
stored in the tissue.[5] The green fleshy leaves range in height from a few centimeters to 2-3
meters or more and have three identifiable layers. The outer layer is a thick cuticle or rind
accounting for about 20%−30% by weight of the whole plant leaf. It consists of upto 18
layers of cells interspersed with chloroplasts where carbohydrates, fats, and proteins are
synthesized. The outer leaf pulp, a thin, mucilaginous layer just beneath and adjacent to the
thick rind, contains vascular bundles acting as the transport system for the plants. Three
types of tubular structures compose the vascular bundles: xylem, which moves water and
minerals from the roots to the leaves; phloem, which takes synthesized minerals to the roots;
and the pericyclic tubule, which stores and transports bitter yellow latex (often referred to as
Aloe sap) along the margin of the leaf. The number of these bundles varies based on the size
of leaves.[6] The inner leaf pulp makes up the majority of the plant by volume, and is
composed of large thin-walled parenchymal cells containing Aloe vera gel, a synonym to
inner leaf, inner leaf fillet, or fillet.

Aloe contains pharmacologically active ingredients associated with diverse biological

activities including fungicidal, antiviral, antibacterial, anti-inflammatory, antimicrobial,
laxative, immunomodulating, and anticancer effects.[3] Aloe vera, known as the “plant of
immortality” in early Egypt, has been used as a traditional medicine in Arab, Chinese,
Egyptian, Greek, Indian, Japanese, Korean, and Roman cultures[7,8] for more than 2000 years
to empirically treat a broad list of disorders and ailments, such as skin problems (wounds, x-
ray and radium burns, and psoriasis), constipation, external and internal ulcers,
[9-12]
hyperlipidemia, diabetes, and lupus erythematosus.[9-12] Due to the numerous purported
beneficial effects, Aloe vera production has been an emerging industry for making laxative
drugs, cosmetics, and functional food, such as face and hand creams, foundations, cleansers,
lipsticks, suntan lotions, shampoos and hair tonics, shaving preparations, bath aids, makeup
and fragrance preparations, baby lotions and wipes, yogurt, drinks, capsules, and tablets. In
order to show current pharmacological and/or toxicological research status on Aloe, we
performed a literature search in PubMed using “Aloe” and specific country names as key
words (Table 1). A total of 1895 and 975 publications were identified when using “Aloe” as
key word in All Fields Not Author and MeSH term databases, respectively. More than half
(51%−60%) of these studies were conducted in the top 10 countries (Table 1), and about one
third of them are from five Asian countries, including China, India, Japan, Korea, and Iran.
However, only about 8% of these articles investigated Aloe-related toxicity in vitro and in
vivo (Table 1).

Table 1.

Pharmacological and/or toxicological research on Aloe based on PubMed online search.*

Country All fields# MeSH term

Aloe All 1895 975

China 267 76

India 191 90

USA 188 95

Japan 110 61

South Africa 93 47

Korea 72 44

Iran 65 22

Italy 55 22
UK 48 21

Brazil 39 21

Top 10 countries 1128 (60%) 499 (51%)

Toxicity-related 150 (8%) 81 (8%)

*Searched on July 17,2015.

#All fields but not in authors.
Although Aloe vera has long been considered as a safe functional food material that can be
used orally and topically,[13] on many occasions it has not been as safe as commonly thought.
Recently, the reported adverse effects in humans and toxicity, genotoxicity, and
carcinogenicity in both in vitro and in vivo studies raise questions as to whether the
components in Aloe vera may have tumor-promoting activities in humans. Due to its
widespread human exposure and concerns that some components may cause cancer, in 1998
the National Cancer Institute nominated Aloe vera as a high-priority candidate for a
carcinogenicity study under the National Toxicology Program (NTP). In 2002, the US Food
and Drug Administration (FDA) issued a final rule stating that use of Aloe as a
nonprescription laxative drug is no longer generally recognized as safe and effective.[14]
Recently, Aloe vera whole leaf extract has been classified by the International Agency for
Research on Cancer as a possible human carcinogen (Group 2B), along with other natural
products such as Ginkgo biloba extract and kava extract.[15,16]

The Aloe vera whole leaf extract, as well as the two primary components (the gel and the
latex or exudates) of the leaf, have been used for various reasons in traditional medicine.
Generally, the gel is used topically to soothe wounds, burns, and skin irritations, and the latex
is recognized to possess cathartic effects. Nevertheless, there is still some confusion
surrounding the whole leaf extract, the gel, and the latex. Given that the beneficial properties
of Aloe vera have been addressed comprehensively and that the gel and the latex possess
distinct components and medical purposes,[5] in this article, the whole leaf extract, the gel,
and the latex associated toxicity, genotoxicity, and carcinogenicity both in vitro and in vivo
are reviewed, and adverse clinical effects in humans are also summarized.

2. Aloe vera whole leaf extract

2.1. Components

Aloe vera whole leaf extract, including the gel and the latex, contains more than 200
chemical substances.[4] The raw Aloe leaf is composed of approximately 98.5% water, the
remaining solid material contains a range of compounds including nutrients (e.g.,
carbohydrates, amino acids, vitamins, and minerals) and non-nutrients (e.g., organic acids,
lignins, phenolic compounds, anthraquinones, and phytosterols). The chemical composition
and the potency of the various constituents are influenced by many factors, such as
species/subspecies, climate, land and irrigation, cultivation methods, harvesting, extraction
processing, and storage conditions.[4,5]

To determine whether the presence of the latex alters the physical and chemical properties in
whole leaf extract, the decolorized Aloe vera whole leaf has been studied for its toxicity and
potential carcinogenicity. The decolorized extract was prepared by activated carbon-
adsorption of the whole leaf extract (1%, w/w) to remove the latex portion of the plant,
mainly anthraquinones, the components giving Aloe vera its laxative properties. However,
some of the high molecular weight polysaccharides of the inner leaf Aloe gel can also be
removed by charcoal absorption. Chemical analysis revealed that the concentrations of aloin,
the principle anthraquinone of Aloe vera latex, differed by a factor of 100 in unfiltered and
filtered extracts (8 mg/g for whole extract and 0.08 mg/g for decolorized extract).[17] The
high-performance liquid chromatography (HPLC) analysis showed large differences between
the two extracts (Fig. 1), indicating that the activated carbon-filtration eliminated a large
number of components from the extract.[18] In addition, Aloe vera decolorized leaf extract
exhibited a reduction in rheological values and approximately 19%−23% lower content of
complex polysaccharides than either the gel or whole extract.[5]

Figure 1.

Representative reversed-phase HPLC profiles of Aloevera whole leaf extract and decolorized whole leaf
extract. Five mg/ml samples were dissolved in Fischer’s medium with pH adjusted to 7.0-7.2. HPLC
analysis was performed using a Phenomenex Prodigy 5 μmODS column (4.6 mm x 250 mm) eluted with
methanol with a linear gradient of 20%−60% water over 30 min and 60-100% methanol over 30 min at a
flow rate of 1 ml/min.

2.2. Toxicity, genotoxicity, and carcinogenicity

2.2.1. Toxicity of the whole leaf extract Logarto Parra and colleagues[19] investigated the
toxicity of Aloe vera (L.) Burm. F. (Aloeaceae) extract using both in vitro and in vivo assays.
Twenty-four hours following an acute oral exposure to Aloe vera dried leaf extract, the
medium lethal concentration (LC50) in brine shrimp was estimated as 3.59 μg/ml and the
lethal dose (LD50) in Swiss albino mice was 120.65 mg/kg. Another acute toxicity study
demonstrated a maximum tolerated dose of 100 mg/kg body weight and LD50 of 250 mg/kg,
when the whole Aloe vera plant powder was extracted with 50% ethanol and administered
intraperitoneally to adult albino mice at an initial dose of 400 to 500 mg/kg.[20] In addition,
Aloe vera whole-leaf material caused a dose-dependent decrease in the viability in HeLa and
HepG2 cells with half-maximal cytotoxic concentration (CC50) values of 413.9 and 439.0
mg/ml, respectively, following a 4-h treatment.[21] It also caused a dose-dependent increase
of apoptosis in HeLa cells at concentrations up to 1000 mg/ml.

In a subchronic toxicity study, 88 Sprague Dawley rats were fed Aloe whole leaf powder at
doses of 2, 4, and 8 g/kg body weight (2.5%, 5%, and 10% Aloe in diet) for 90 days.[22] All
dosed rats increased defecation and rats treated with the high doses also showed reduced food
efficiency and body weight. Relative kidney weight was significantly increased in males
exposed to 8 g/kg body weight and all dosed females. All of the exposed groups displayed a
significant increase in the incidences of pigmentation in renal tubular, mesenteric lymph
nodes and lamina propria of the colonic mucosa, and proliferation in mesenteric lymph
nodes. Reproductive toxicity was observed after a chronic oral ingestion of 100 mg/kg Aloe
vera extract per day, which is one-fifth of the pharmacologically active dose, for a period of 3
months.[23] This was manifested by significant sperm damage, hematological changes,
inflammation, and mortality as compared to control animals.

As part of a 14-day drinking water study conducted by the NTP, Aloe vera nondecolorized
whole leaf extract and decolorized extract were administered to groups of four male and four
female F344/N rats and the same numbers of B6C3F1 mice at 7 weeks of age.[24] The malic
acid content of 0.5%−3% Aloe vera whole and decolorized extract solutions was 970-5820
μg/g and 1240-7440 μg/g water, respectively, and aloin A content was 70-422 μg/g and 0.8-
4.5 μg/g water, respectively. After 14 days female rats exposed to 1.5%—3% of decolorized
extract displayed significantly decreased blood urea nitrogen levels, whereas rats exposed to
3% whole extract displayed reduced body weight, water consumption, gastrointestinal tract
transit times, and liver, heart, spleen, thymus, and kidney weight than those of controls.
Leukocyte and erythrocyte counts and hematocrit percentages were significantly elevated in
both male and female rats. In contrast, only a significant increase in water consumption was
observed in female mice that received 2.0% nondecolorized whole extract.[24]

In comparison to this study, a highly purified decolorized whole leaf Aloe vera (L.) Burm. f.
juice (total anthraquinones < 0.1 parts per million) was administered to F344/Du rats via
drinking water at concentrations up to 2% (w/v).[25] This study was designed to compare the
results obtained from other in vivo studies using whole leaf extract, specifically the NTP
study reported by Boudreau and colleagues.[24] No significant toxicological findings were
observed after subchronic exposure for 13 weeks. A similar study also showed no toxicity in
F344 rats after oral administration of a commercially available Aloe vera decolorized extract
beverage up to 13 weeks, as evaluated by behavior, stools, weight gain, feed consumption,
organ weights, and intestinal mucosal morphologies.[26] These results suggest that
anthraquinones may be a major contributor or serve as a marker of other agent(s) for Aloe
vera-induced adverse effects.[25]

2.2.2. Genotoxicity of the whole leaf extract The genotoxicity of water extracted Aloe ferox
was studied using the Bacillus sub-tilis rec-assay in the 1980s. Aloe ferox is a palm-like
succulent with many sharp reddish-brown spines on the margins of the leaves, giving the
plant name “ferox” that means “fierce” or “war-like” in Latin. In the absence of metabolic
activation, the lengths of inhibition zones formed by 6 mg of Aloe extraction on Rec+ and
Rec- strains deviated distinctly from those of negative control samples, indicating a positive

[27]
response in the Bacillus subtilis spore rec-assay.[27] However, no genotoxic effects were
observed in the histidine reversion Ames test and DNA repair assays using Aloe vera
decolorized extract beverage at up to 21 × concentrations.[26]

Recently, Aloe vera whole extract- and decolorized extract-induced cytotoxicity and
genotoxicity were evaluated in our laboratory using the mouse lymphoma assay (MLA).[18]
This study used the same test articles that were used for the 14-day studies by the NTP.[24]
After a 24-h treatment, both extracts exhibited concentration- dependent cytotoxicity and
mutagenicity in the mouse lymphoma cells, with whole extract showing a positive response
at lower concentrations than the decolorized extract. Molecular analysis of induced mutant
colonies revealed that 77%−92% of the large colonies and 100% of the small colonies from
both treatments lost heterozygosity at the Tk locus and about half of the mutants lost
heterozygosity at both the Tk and D11Mit42 loci, thus affecting approximately 6-30
centimorgans of the chromosome (Fig. 2). These results indicate that the primary type of
damage from both treatments was large chromosome mutations (deletions and/or mitotic
recombination). In addition, intracellular reactive oxygen species (ROS) levels induced by
decolorized extract was about three-fold higher than that of whole extract in treated cells,
suggesting that during the process of activated carbon filtration, some mutagenic components
were removed from whole extract and other components with pro-oxidative or mutagenic
activities, or both, might be enriched. Another important finding in this study was that the
mutagenicity of the decolorized extract was detected at doses of about twice that required for
whole extract-induced mutagenicity. Since the anthraquinone content was reduced by 99% in
the decolorized extract relative to the whole extract, these results indicate that
anthraquinones are not the only mutagenic component of these mixtures and Aloe-induced
genotoxicity may not be eradicated completely by removing these chemicals from Aloe
preparations.[18]

Figure 2.

Comparison of the percentage of mutational types for all (large and small) colonies produced in cells
treated with Aloe vera. Mouse lymphoma cells were treated for 24 h with 4.5 or 5 mg/ml whole leaf
extract, or 8 mg/ml decolorized extract. Whole extract at 4.5 or 5 mg/ml or decolorized extract vs
control, p < 0.0001; 4.5 mg/ml whole extract vs decolorized extract, p = 0.03; 4.5 mg/ml vs 5 mg/ml
whole extract, p = 0.37; 5 mg/ml whole extract vs decolorized extract, p = 0.26. Data from Table 3 in
[18].
2.2.3. Carcinogenicity of the whole leaf extract NTP Technical Report 577 described clear
evidence of carcinogenic activity in F344/N rats after oral administration of Aloe vera whole
leaf extract in drinking water for two years.[28] In this study, F344/N rats and B6C3F1 mice
were exposed to 0%, 1%, 2%, or 3% (wt/wt) extract for a period of 13 weeks or 2 years. The
13-week exposure caused increased incidences of goblet cell hyperplasia in the large
intestine of both rats and mice when compared to the control. The two-year study
demonstrated significant dose-related increases in the incidences of adenomas and/or
carcinomas of the ileocecal and cecal-colic junction, cecum, and the ascending and
transverse colon in male and female rats in the high-dose groups.[28] Whole extract-induced
large intestinal tumors in F344 rats and human colorectal cancers shared similar changes in
morphology and in molecular pathways, such as MAPK, WNT, and TGF-β signaling.[29] In a
one-year study using Wistar Hannover rats, 4% Aloe arborescens (whole leaf powder extract)
in the diet resulted in diarrhea, reduced body weight gain, yellowish pigmentation of
ileocecal lymph nodes and renal tubules and severe sinus dilatation of the ileocecal lymph
nodes.[30] In the subsequent two-year study, adenomas or adenocarcinomas in the cecum,
colon, and rectum were observed in the 4% male group, and adenomas were observed in the
4% female group. The irritation of the intestinal tract may contribute to the equivocal
carcinogenic potential in the colon.[31] Due to the potential phototoxicity of herbal products,
[32]
Aloe whole leaf or decolorized whole leaf creams was applied topically in male and
female SKH-1 hairless mice for one year.[33] Both products showed a weak enhancing effect
on the photocarcinogenic activity of simulated solar light, as manifested by significantly
increased histopathologically-determined squamous cell neoplasm in some mice.

2.3. Adverse clinical effects of the whole leaf extract in humans

Topical and oral use of Aloe vera can cause skin irritation, hives, cramping, and diarrhea to
those who are allergic to other plants in the lily family, for example, onion and tulips. Several
case reports on toxicity or hypersensitivity of Aloe products in humans are available, but
there are no published controlled toxicology stud- ies.[34] A 35-year-old woman experienced
massive intraoperative bleeding after oral consumption of Aloe vera tablets for two weeks
before the surgery for leg pain. Compounds contained within Aloe vera can reduce the
synthesis of prostaglandin, thus inhibiting secondary aggregation of platelets. Sevoflurane, a
general anesthetic, inhibits thromboxane A(2) formation by suppressing cyclooxygenase
activity. Since both sevoflurane and Aloe vera have antiplatelet effects, the bleeding could
have been due to a possible herb-drug interaction between Aloe vera and sevoflurane.[35] A
47-year-old man developed acute oliguric renal failure and liver dysfunction after ingestion
of Cape Aloes, a previously described nephrotoxin.[36]

Hepatotoxicity is considered one of the most reported adverse effects caused by herbal
dietary supplements.[37] The first case of acute hepatitis due to the ingestion of Aloe vera
compound was reported in 2005 in Germany.[38] Afterward, cases of Aloe-induced toxic
hepatitis were reported in Turkey,[39] United States,[40] Argentina,[41], and Korea.[42] A total
of six females and two males were admitted to hospital for acute hepatitis after taking Aloe
preparation over 3-260 weeks.[43] Their clinical manifestation, liver biopsy, and laboratory
findings supported the diagnosis of toxic hepatitis. All eight patients showed improved
conditions after discontinuing this medication. These cases emphasize the importance of
considering phytophar- maceutical over-the-counter drugs as causative agents in
hepatotoxicity.

3. Aloe vera latex or exudate

3.1. Components

Aloe vera latex or exudate is distributed within vascular bundles located between the plant’s
outer skin (rind) and the pulp. The pericyclic tubules, one of the three types of tubular
structures of vascular bundles, store and transport Aloe vera latex along the margin of the
leaf. The latex is yellow-brownish in color and has a bitter taste. About 80 chemical
constituents have been isolated by liquid chromatography in the latex, and most of the
compounds are phenolic in nature, mainly anthraquinone C- glycosides, anthrones, and free
anthraquinones.[44,45] Barbaloin, also known as aloin A, is identified as the major constituent
in the latex.[5,46] The other three main components are isobarbaloin (aloin B), aloesin
(aloeresin B), and aloeresin A.[47] The latex also contains several other
anthraquinones/anthrones and chromones including aloe-emodin, aloeresin E, aloenin,[44] as
well as some aromatic compounds, for example, aldehydes (butanal, pentanal, etc.) and
ketones (2-butanone, 2-heptanone, etc.).[47]

3.2. Toxicity, genotoxicity, and carcinogenicity

Aloe vera latex contains a number of biologically active compounds, notably anthraquinones.
Various in vitro and in vivo assays have been performed to evaluate the cytotoxicity,
genotoxicity, and carcinogenicity of the chemical components contained within the latex,
most especially aloe-emodin, aloin, emodin, and dan- thron.

3.2.1. Toxicity of the latex The cytotoxicity of aloe-emodin has been investigated intensively.
Aloe-emodin induced apoptosis through various mechanisms, including a p53-dependent
pathway in T24 human bladder cancer cells[48] and G2/M cell cycle arrest in human
promyelocytic leukemia HL-60 cells.[49] During the apoptosis process induced by aloe-
emodin and emodin in human lung squamous carcinoma cells (CH27) and human lung
nonsmall cell carcinoma cells (H460), increases in cytosolic cytochrome c, caspase-3
activation, and changes of protein kinase c (PKC) isozymes were observed.[50] This study
also demonstrated that PKC stimulation occurred at a site downstream of caspase-3 in the
emodin-mediated apoptotic pathway. Another study demonstrated that aloe-emodine

[51]
significantly inhibited proliferation and induced apoptosis in adult human keratinocytes.[51]
The impairment of ker- atinocyte proliferation could be observed at concentrations far below
the industry standards for commercial products containing Aloe extract.

The toxicity of aloin was evaluated in human Jurkat T lymphocytes using flow cytometry and
microscopy.[52] Aloin treatment resulted in decreased cell size, increased granularity, a block
at the G2/M phase of the cell cycle, and loss of both membrane integrity and mitochondrial
membrane potential in a dose-dependent manner, suggesting a mitochondrial-dependent
pathway for aloin-induced apoptosis. UP780, a standardized composition of aloe chromone
aloesin formulated with an Aloe vera inner leaf fillet, showed a no-observed-adverse-effect-
level in CD-1 mice with oral administration of UP780 at doses of 2 g/kg/d for 14 days or up
to 1 g/kg/d for 90 days.[53]

3.2.2. Genotoxicity of the latex The genotoxicity of some anthraquinones has been confirmed
in a variety of in vitro and in vivo assay systems. A high proportion of anthraquinones was
reported to be mutagenic in a number of strains of Salmonella typhimurium, for example,
TA1537, TA1538, TA102, and TA98.[54-56] These strains are particularly sensitive to
frameshift mutagens. Danthron and aloe-emodin were positive in strain TA1357 both with
and without metabolic activation.[55] Aloe-emodin also induced increased revertant colonies
in strains TA 1537, TA 1538, and TA 98.[57] Muller and colleagues[58] investigated the
genotoxicity of three anthraquinones, emodin, danthron, and aloe-emodin using the MLA,
micronucleus test, and the Comet assay. At micromolar concentrations, all three compounds
induced concentration- dependent increases in micronuclei and moderate increases in mutant
frequency in L5178Y cells. Danthron and aloe-emodin also increased DNA breaks at a
concentration of 50 μM in the Comet assay. The genotoxicity and mutagenicity induced by
these anthraquinones were due to the inhibition of the catalytic activity of topoisomerase II
(Topo II), with danthron being the most potent.[58,59] Emodin, the least potent compound
among the three anthraqinones, caused DNA doublestrand breaks by stabilizing Topo II-
DNA cleavage complexes and by inhibiting ATP hydrolysis of Topo II.[60] Aloe-emodin
caused DNA damage in human lung carcinoma cells through the production of ROS,[61]
induced micronuclei in TK6 human lymphoblastoid cells,[56] and chromosomal aberration in
Chinese hamster ovary cells.[57] Danthron caused DNA damage and caspase cascade-
mediated apoptosis in SNU-1 human gastric cancer cells through mitochondrial permeability
transition pores and Bax-triggered pathways.[62]

An in vivo mouse Comet assay was performed on isolated kidney and colon cells of male
OF1 mice in order to demonstrate the possible organospecific genotoxicity of aloe-emodin.
[56] Increases in DNA strand breaks in both the kidney and the colon were observed between

3 h and 6 h after two oral administrations at 500,1000, and 2000 mg/kg body weight,
suggesting an in vivo genotoxic mechanism of action.
3.2.3. Carcinogenicity of the latex Tumor promotion activities, such as stimulation of cell
proliferation and enhancement of malignant transformation, have been investigated in mice
for 9 hydroxyan- thraquinones (HA) including danthron, aloe-emodin, and emodin.[63] A 2 to
3-fold increase in DNA synthesis was found in primary rat hepatocytes exposed to danthron
and aloe-emodin; and danthron also enhanced malignant transformation of C3H/M2 mouse
fibroblasts pretreated with N-methyl-N’-nitro-N-nitrosoguanidine or 3-methylcholanthrene,
suggesting that HA with hydroxy groups in the 1,8- positions may have tumor-promoting
activity. The carcinogenic potential of HA also has been demonstrated in a group of 29 male
ACI/N rats.[64] After 480 days feeding with 1% of HA, 25 of 29 rats developed adenomas or
adenocarcinomas in the cecum or upper portion of the colon; liver neoplasms (neoplastic
nodules and hepatocellular carcinomas) were observed in 12 rats; and benign stomach tumors
were observed in five animals. These findings strongly suggest that HA is carcinogenic in
rodents.

A two-year feeding study of emodin in male and female F344/N rats and B6C3F1 mice
showed equivocal evidence of carcinogenic activity for emodin in female F344/N rats due to
a marginal increase in the incidence of Zymbal’s gland carcinoma and in male B6C3F1 mice
based on a low incidence of renal tubule neoplasms.[65] In the rat study, diets containing 0,
280, 830, or 2500 ppm emodin (equivalent to average daily doses of approximately 110, 320,
or 1000 mg/kg to males and 120, 370, or 1100 mg/kg to females) were administered to 65
male and 65 female rats for 105 weeks. Three Zymbal’s gland carcinomas were diagnosed in
female rats exposed to 2500 ppm. In the mouse study, 60 male and female mice were fed
diets containing 0-625 ppm (equivalent to average daily doses of approximately 15-70
mg/kg) or 0-1250 ppm (equivalent to average daily doses of approximately 30-120 mg/kg)
emodin, respectively, for 105 weeks. Low incidences of renal tubule adenoma and one
carcinoma each in the 312 and 625 ppm groups were observed in exposed male mice. No
evidence of carcinogenic activity of emodin was found in female B6C3F1 mice even at the
highest dose of 1250 ppm.

Evidence for aloe-emodin photocarcinogenicity was found in C3H mice after combined
treatment with ultraviolet radiation and aloe-emodin in ethanol vehi- cle.[66] C3H/HeN mice
were treated with aloe-emodin in 25% ethanol topically three times per week for two weeks
and exposed to 15 kJ/m2 UVB (280-320 nm) radiation. Primary cutaneous melanin-
containing tumors were diagnosed in 50%−67% of the UV-irradiated mice given aloe-
emodin in ethanol vehicle and in 20%−30% of the mice treated with a combination of UV
radiation and ethanol vehicle, whereas no skin tumors were induced by aloe-emodin alone in
the absence of UV radiation.

3.3. Adverse clinical effects of the latex in humans

The purgative effect of Aloe latex has long been recognized and has been used empirically to
relieve constipation. The earliest medical writer to record the therapeutic use of Aloe is
Dioscorides, a Greek physician of the first century A.D.[67] Subsequently, Aloe latex was
used widely in herbal laxative preparations in many countries. Thus, a number of adverse
effects resulting from ingestion of latex have been reported in clinical studies. Prolonged use
was associated with electrolyte imbalance due to diarrhea, abdominal pain, vomiting,
hypokalemia, pseudomelanosis coli, and the development of a cathartic colon—the colon
becomes atonic and dilated. Longterm use of anthranoid laxatives might be correlated with
the risk of developing colon cancer.[68]

A case of Aloe-induced Henoch-Schonlein purpura, an idiopathic vasculitis of the small

vessels, was reported. A 52-year-old male patient from Pakistan presented severe arthralgia,
palpable purpura, and abdominal pain ten days after taking some juice extracted from four to
five leaflets of Aloe vera. Twenty-four hours after the juice consumption, the man started to
have rash on his legs and a mild arthralgia of the ankle. His symptoms worsened in the
following days, and he developed diffuse, colicky, abdominal pain. Marked segmental
necrosis and crescent formation were demonstrated by a renal biopsy. The renal dysfunction
and nephritis were considered to be a consequence of large doses of Aloe.[69]

A 74-year-old female presented with an impressive deep black pigmentation of the whole
colon after chronic use of anthraquinone laxatives over many decades. Various adenomas,
which were classified as precancerous lesions, were detected, but no colorectal carcinoma
was found.[70] An 18-year-old Caucasian girl, who was treated with a combination laxative
containing 5 ml danthron orally at night to ameliorate constipation from 14 months old to 5-6
years old, presented a small bowel leiomyosarcoma with widespread dissemination.[71]
Although one case cannot prove a causative association between danthron and the risk of
developing bowel cancer, the authors concluded that prolonged oral exposure to the laxative
should be avoided in early childhood. In addition, pregnant women were advised not to take
Aloe latex because its cathartic property might result in stimulating uterine contractions,
thereby increasing the risk for premature labor or miscarriage. Also, nursing mothers should
not take laxatives because of the possibility of anthraquinones causing diarrhea in the infants.
[3]

4. Aloe vera gel

4.1. Components

Aloe vera gel is a transparent mucilaginous jelly-like substance contained in the

parenchymatous cells of fresh Aloe vera leaf pulp, with a gel yield of approximately 70% (70
g gel/100 g pulp) from the pulp by mechanical extrusion.[72] The gel has very high water
content (99%−99.5%), with the remaining soluble solids making up 0.5%−1%,[73] and a

[74]
range of gel acidity (pH) of 4.4-4.7.[74] On a dry matter basis, the chemical constituents
consist of 35% dietary fibers (nonstarch polysaccharides + lignin), 27% soluble sugars, 24%
ash, and a minor fraction of lipids, proteins, enzymes, and mineral elements.[7,72] The alcohol
insoluble residues obtained from Aloe vera gel lyophilized fractions have a high content of
carbohydrates (72%) including mannose, glucose, and uronic acids. Linear chains of β−1-4-
linked mannose and glucose molecules compose the primary polysaccharides at a ratio of
1~22:1 in the gel.[6,7,75-77] Most investigators agree that acemannan, an acetylated
glucomannan, makes up the major active component of the mucilaginous Aloe vera gel,[72]
while others report pectic substance as the main polysaccharide.[73] The discrepancies are
considered to be a result of differences in the species, seasons of the year, geographical
locations, and the gel extraction process.

4.2. Toxicity, genotoxicity, and carcinogenicity

The toxic effects of Aloe vera gel have been reported only in a few studies. There is diversity
in the results of the observed toxic effects which may be largely due to the differences in the
gel contents that are greatly influenced by a variety of factors including seasons, locations,
irrigation, harvest time, and, most importantly, the lack of standardization of the gel
preparations.

4.2.1. Toxicity of the gel The cytotoxicity of Aloe vera gel has been confirmed in monolayers
of chicken fibroblasts based on the observations of disrupted intercellular junctions and the
formation of cell-free gaps in the monolayers after treatment.[78] The cell injury assay was
conducted using three fractions isolated from the Aloe barbadensis leaves, native gel
(mucilaginous parenchymous tissue scraped from Aloe leaves), purified gel (the
nondialyzable fraction of the native gel), and the low molecular weight fraction (LMWF, the
dialyzable material). A 1:10 dilution of native gel and the LMWF promoted similar cell
injuries, while the purified gel behaved like the control at the same dilution. These severe
cellular damages were distinct enough to be detected under a microscope. Therefore, it was
proposed that the toxicity was mainly caused by the LMWF from the gel since the beneficial
characteristics were suggested to result from the high molecular weight components.[78]
Following a 4-hour treatment, an Aloe vera dehydrated gel material induced dose-dependent
cytotoxicity in HeLa cells, with a CC5o value of 269.3 mg/ml.[21]

Aloe vera gel was administered in drinking water to groups of four male and four female
F344/N rats in a 14-day study conducted by the NTP.[28] The gel quality was monitored by
the content of malic acid and aloin A (barbaloin). Drinking water solutions of 0.5%−3% Aloe
vera gel contained 1060-6360 μg malic acid/g water, and 5.6-33.3 μg aloin A/g water. After
the 14-day exposure, dose-related increases in urine glucose levels in female rats and dose-
related decreasing trends in serum levels of triglycerides, cholesterol, and albumin were
observed at concentrations of 1.5% or greater in female rats and of 3.0% in male rats. When
adult male Wistar rats were orally administered with Aloe vera gel extract solution (150 and
300 mg/kg/day) for 8 weeks, the weight of testes, serum testosterone, sperm count, and
sperm fertility were significantly decreased compared to the control rats.[79] In another in
vivo study using a commercial stabilized Aloe vera gel consumed as a beverage, no changes
were found in feed consumption, body weight gain, and serum chemistry tests following a
13-week subchronic exposure in B6C3F1 mice.[80]

After 5.5 months ingestion of crude skinned Aloe filet to male F344 rats, no adverse effect
was observed on body weight gain, food intake, gastrointestinal transit time, or gross
pathology at dietary concentrations of 1% or 10% (corresponding to doses of Aloe vera gel of
~0.33 and 3.3 g/kg bw/day).[16,81] Life-long ingestion of low dose (1%) Aloe vera filet caused
no obvious harmful effects or deleterious changes in the rat.[82]

4.2.2. Genotoxicity of the gel Studies on the biological effects of Aloe vera pulp extract on
Escherichia coli-deficient repair mutants and plasmid DNA revealed genotoxic properties of
the gel, but not cytotoxicity because of the poor permeability through the cell membrane.
The agarose gel electrophoresis assay showed that Aloe vera pulp extract produced dose-
dependent single-strand breaks in the plasmid DNA.[83] In vitro and in vivo safety studies
using a high-purity Aloe vera inner leaf fillet preparation demonstrated that the gel was
nonmutagenic in the Ames test, the chromosomal aberration test, and the in vivo bone
marrow micronucleus test, following oral administration at doses up to 5 g/kg bw/day to rats
for 90 days[84] Similarly, a commercial gel juice did not induce a significant increase in SOS
DNA repair in Escherichia coli or mutagenesis in Salmonella TA100[80]

4.2.3. Carcinogenicity of the gel No carcinogenicity data are available for Aloe gel.

4.3. Adverse clinical effects of the gel in humans

Aloe gels were first used clinically in the 1930s for the treatment of radiation burns.[34]
Afterward, several clinical trials of Aloe vera gel have been carried out in the treatment of
burn wounds,[85] oral lichen planus,[86] hyperlipidemic type 2 diabetic patients,[87] and
recurrent aphthous stomatitis.[88] Only some minor adverse effects were reported in these
studies, such as discomfort, pain, and the development of hypersensitive reactions. However,
generalized eczematous and papular dermatitis were found in a male patient in response to
the oral and topical use of the Aloe vera gel.[89] Pruriginous erythema was observed on the
legs and eyelids of a 72-year- old woman after applying self-made Aloe vera leaf juice over
the legs.[90] A very slow recovery from the dermatitis induced by Aloe vera preparations was
reported in four cases after dermabrasion and chemical peel.[91] No severe adverse effects or
carcinogenicity have been reported from using Aloe vera gel.

5. Perspectives
More than 300 million people worldwide consume dietary supplements and herbal plants,
and about one-half of Americans use them regularly.[92] Dietary or herbal supplement
products are expected to be safe, effective, and of appropriate quality. However, the complex
chemical nature of dietary supplements makes it difficult to evaluate their efficacy and safety.
Herbal products often exhibit great variability in quality because of some issues including
authentication, adulteration and substitution, and factors during growth, harvest, and
postharvest processing.[93] Authentication of plant species used for preparation of herbal
dietary supplements is important for safety assurance. Besides traditional approaches, the use
of molecular/genetic profiling in identification of specific molecular changes (fingerprints)
and in unveiling signature indicative of exposures remains a promising yet still largely
unexplored approach.[94,95]

The reported adverse effects have raised concerns of public health risks regarding the
concentration, composition, and individual contaminants of dietary supplements. Herbal
dietary supplements and other herbal products have been recognized as the common causes
of drug-induced liver injury.[96] A recent report indicates that dietary/herbal supplements are
implicated in 19% of drug-induced acute liver failure cases,[97] because consumers often
purchase these products online without the supervision of a health care provider and are not
aware of drug-herb interactions and appropriate warnings. A total of 1179 English-language,
herbal product- related websites (including retail and nonretail websites) were examined and
only ~10% of them recommended consultation with a health care professional. In addition,
only about 8% of internet retailers provided information on potential adverse effects, drug
interactions, and other basic safety precautions; and less than 3% cited scientific references to
their claims.[98]

Aloe plant contains multiple constituents with potential beneficial and toxico- logical
activities. Three distinct preparations derived from Aloe vera (i.e., the whole leaf extract,
Aloe vera gel, and Aloe vera latex) have been used as topical and oral therapeutic remedies.
The gel is primarily used topically for wounds and skin problems, as well as taken orally for
the treatment of gastrointestinal ulcers and dia- betes.[9] The latex is regulated as a drug by
the FDA to relieve constipation and the whole leaf extract may possess antibacterial/viral and
anticancer activities.[5] Aloe vera appears to be safe when used as a flavoring in foods[16]; and
the polysaccharide material derived from the inner gel is noncytotoxic as evaluated by the
Cosmetic Ingredient Review Expert Panel.[3] However, due to the cytotoxicity, mutagenicity,
and carcinogenicity of anthraquinones, it is crucial to monitor the content of these phenolic
compounds in Aloe vera whole leaf extract and latex.[5,24] The International Aloe Science
Council standard suggests that the maximum allowable aloin content in Aloe-derived
material for oral consumption is less than 10 ppm (parts per million); for nonmedical use the
recommended limit is 50 ppm or lower.[3,99]
According to Multinational Integrated Data Analysis conducted by IMS Health (Danbury,
CT), the estimated global sales of Aloe products have reached US $351 million.[16] Due to
the increased popularity and utilization of Aloe plant, indepth studies are needed to
investigate the adverse effects, conventional drug interactions, and the possible toxic and
carcinogenic effects of Aloe preparations, especially after long-term use of these products.

Acknowledgments

We thank Drs. Robert H. Heflich, Page B. McKinzie, and Vasily N. Dobrovolsky for their
helpful suggestions and comments. The information in these materials is not a formal
dissemination of information by the US Food and Drug Administration and does not
represent agency position or policy.

References

[1] Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children:
United States, 2007. Natl Health Stat Report. 2008;12:1–23. [PubMed] [Google Scholar]

[2] Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative medicine (CAM) and
frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat Report. 2009;18:1–14. [PubMed]
[Google Scholar]

[3] Cosmetic Ingredient Review Expert Panel (CIR). Final report on the safety assessment of aloe andongensis
extract, aloe andongensis leaf juice, aloe arborescens leaf extract, aloe arborescens leaf juice, aloe arborescens leaf
protoplasts, aloe barbadensis flower extract, aloe barbadensis leaf, aloe barbadensis leaf extract, aloe barbadensis
leaf juice, aloe barbadensis leaf polysaccharides, aloe barbadensis leaf water, aloe ferox leaf extract, aloe ferox leaf
juice, and aloe ferox leaf juice extract. Int J Toxicol. 2007;26(Suppl 2):1–50. [PubMed] [Google Scholar]

[4] Rodriguez Rodriguez E, Darias Martin J, Diaz Romero C. Aloe vera as a functional ingredient in foods.
CritRev Food Sci Nutr. 2010;50:305–326. [PubMed] [Google Scholar]

[5] Boudreau MD, Beland FA. An evaluation of the biological and toxicological properties of Aloe barbadensis
(miller), Aloe vera. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2006;24:103–154. [PubMed]
[Google Scholar]

[6] Ni Y, Turner D, Yates KM, Tizard I. Isolation and characterization of structural components of Aloe vera L.
leaf pulp. Int Immunopharmacol. 2004;4:1745–1755. [PubMed] [Google Scholar]

[7] Grindlay D, Reynolds T. The Aloe vera phenomenon: A review of the properties and modern uses of the leaf
parenchyma gel. J Ethnopharmacol. 1986;16:117–151. [PubMed] [Google Scholar]

[8] Atherton P Aloe vera: Magic or medicine? Nurs Stand. 1998;12:49–54. [PubMed] [Google Scholar]

[9] Reynolds T, Dweck AC. Aloe vera leaf gel: A review update. J Ethnopharmacol. 1999;68:3–37. [PubMed]
[Google Scholar]
[10] Atiba A, Nishimura M, Kakinuma S, Hiraoka T, Goryo M, Shimada Y, Ueno H, Uzuka Y. Aloe vera oral
administration accelerates acute radiation-delayed wound healing by stimulating transforming growth factor-beta
and fibroblast growth factor production. Am J Surg. 2011;201:809–818. [PubMed] [Google Scholar]

[11] Foster M, Hunter D, Samman S. Evaluation of the nutritional and metabolic effects of Aloe vera In: Benzie
IFF, Wachtel-Galor S, eds., Herbal Medicine: Biomolecular and Clinical Aspects. 2nd ed, CRC Press, Boca
Raton, FL; 2011:Chapter 3. http://www.ncbi.nlm.nih.gov/books/NBK92765/ (accessed October, 2015). [Google
Scholar]

[12] Vogler BK, Ernst E. Aloe vera: A systematic review of its clinical effectiveness. Br J Gen Pract.
1999;49:823–828. [PMC free article] [PubMed] [Google Scholar]

[13] Tanaka M, Yamada M, Toida T, Iwatsuki K. Safety evaluation of supercritical carbon dioxide extract of Aloe
vera gel. J Food Sci. 2012;77:T2–9. [PubMed] [Google Scholar]

[14] US Food and Drug Administration. Status of certain additional over-the-counter drug category II and III
active ingredients. Fed Regist. 2002;67:31125–31127. [PubMed] [Google Scholar]

[15] Grosse Y, Loomis D, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Baan R,

Mattock H, Straif K, and International Agency for Research on Cancer Monograph Working Group.
Carcinogenicity of some drugs and herbal products. Lancet Oncology. 2013;14:807–808. [PubMed] [Google
Scholar]

[16] International Agency for Research on Cancer. Aloe vera In: Some Drugs and Herbal Products (Volume 108),
International Agency for research on Cancer, Lyon, France; 2015.
http://monographs.iarc.fr/ENG/Monographs/vol108/mono108.pdf (accessed October, 2015). [Google Scholar]

[17] Xia Q, Yin JJ, Fu PP, Boudreau MD. Photo-irradiation of Aloe vera by UVA—Formation of free radicals,
singlet oxygen, superoxide, and induction of lipid peroxidation. Toxicol Lett. 2007;168:165–175. [PubMed]
[Google Scholar]

[18] Guo X, Zhang S, Dial SL, Boudreau MD, Xia Q, Fu PP, Levy DD, Moore MM, Mei N. In vitro investigation
of the mutagenic potential of Aloe vera extracts. Toxicol Res. 2014;3: 487–496. [PMC free article] [PubMed]
[Google Scholar]

[19] Logarto Parra A, Silva Yhebra R, Guerra Sardinas I, Iglesias Buela L. Comparative study of the assay of
Artemia salina L. and the estimate of the medium lethal dose (LD50 value) in mice, to determine oral acute
toxicity of plant extracts. Phytomedicine. 2001;8:395–400. [PubMed] [Google Scholar]

[20] Dhar ML, Dhar MM, Dhawan BN, Mehrotra BN, Ray C. Screening of Indian plants for biological activity: I.
Indian J Exp Biol. 1968;6:232–247. [PubMed] [Google Scholar]

[21] du Plessis LH, Hamman JH. In vitro evaluation of the cytotoxic and apoptogenic properties of aloe whole leaf
and gel materials. Drug Chem Toxicol. 2014;37:169–177. [PubMed] [Google Scholar]

[22] Zhou Y, Feng Y, Wang H, Yang H. 90-day subchronic toxicity study of aloe whole-leaf powder. Wei Sheng
Yan Jiu. 2003;32:590–593. [PubMed] [Google Scholar]
[23] Shah AH, Qureshi S, Tariq M, Ageel AM. Toxicity studies on six plants used in the traditional Arab system of
medicine. Phytotherapy Res. 1989;3:25–29. [Google Scholar]

[24] Boudreau MD, Beland FA, Nichols JA, Pogribna M. Toxicology and carcinogenesis studies of a
nondecolorized whole leaf extract of Aloe barbadensis Miller (Aloe vera) in F344/N rats and B6C3F1 mice
(drinking water study). Natl Toxicol Program Tech Rep Ser. 2013;577:1–266. [PubMed] [Google Scholar]

[25] Shao A, Broadmeadow A, Goddard G, Bejar E Frankos V. Safety of purified decolorized (low anthraquinone)
whole leaf Aloe vera (L) Burm. f. juice in a 3-month drinking water toxicity study in F344 rats. Food Chem
Toxicol. 2013;57:21–31. [PubMed] [Google Scholar]

[26] Sehgal I, Winters WD, Scott M, David A, Gillis G, Stoufflet T, Nair A., Kousoulas K. Toxicologic assessment
of a commercial decolorized whole leaf aloe vera juice, lily of the desert filtered whole leaf juice with aloesorb. J
Toxicol 2013:802453. [PMC free article] [PubMed] [Google Scholar]

[27] Morimoto I, Watanabe F, Osawa T, Okitsu T, Kada T. Mutagenicity screening of crude drugs with Bacillus
subtilis rec-assay and Salmonella/microsome reversion assay. Mutat Res. 1982;97:81–102. [PubMed] [Google
Scholar]

[28] National Toxicology Program. Toxicology and carcinogenesis studies of a non-decolorized whole leaf
extract of Aloe vera in F344/N rats and B6C3F1 mice. http://ntp.niehs.nih.gov/ntp/htdocs/lt_rpts/tr577_508.pdf
(accessed October, 2015). [PubMed]

[29] Boudreau MD, Mellick PW, Olson GR, Felton RP, Thorn BT, Beland FA. Clear evidence of carcinogenic
activity by a whole-leaf extract of Aloe barbadensis miller (aloe vera) in F344/N rats. Toxicol Sci. 2013;131:26–
39. [PMC free article] [PubMed] [Google Scholar]

[30] Matsuda Y, Yokohira M, Suzuki S, Hosokawa K, Yamakawa K, Zeng Y, Ninomiya F, Saoo K, Kuno T,
Imaida K. One-year chronic toxicity study of Aloe arborescens Miller var. natalensis Berger in Wistar Hannover
rats. A pilot study. Food Chem Toxicol 2008;46:733–739. [PubMed] [Google Scholar]

[31] Yokohira M, Matsuda Y, Suzuki S, Hosokawa K, Yamakawa K, Hashimoto N, Saoo K, Nabae K, Doi Y,
Kuno T, Imaida K. Equivocal colonic carcinogenicity of Aloe arborescens Miller var. natalensis berger at high-
dose level in a Wistar Hannover rat 2-y study. J Food Sci. 2009;74:T24–30. [PubMed] [Google Scholar]

[32] Fu PP, Xia Q, Zhao Y, Wang S, Yu H, Chiang HM. Phototoxicity of herbal plants and herbal products. J
Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2013;31:213–255. [PubMed] [Google Scholar]

[33] National Toxicology Program. Photocarcinogenesis study of aloe vera [CAS NO. 481-72- 1(Aloe-emodin)] in
SKH-1 mice (simulated solar light and topical application study). Natl Toxicol Program Tech Rep Ser.
2010;553:7–103. [PubMed] [Google Scholar]

[34] Steenkamp V, Stewart MJ. Medicinal applications and toxicological activities of Aloe products. Pharm Bio.
2007;45:411–420. [Google Scholar]

[35] Lee A, Chui PT, Aun CS, Gin T, Lau AS. Possible interaction between sevoflurane and Aloe vera. Ann
Pharmacother. 2004;38:1651–1654. [PubMed] [Google Scholar]
[36] Luyckx VA, Ballantine R, Claeys M, Cuyckens F, Van den Heuvel H, Cimanga RK, Vlietinck AJ, De Broe
ME, Katz IJ. Herbal remedy-associated acute renal failure secondary to Cape aloes. Am J Kidney Dis.
2002;39:E13. [PubMed] [Google Scholar]

[37] Guo L, Mei N, Xia Q, Chen T, Chan PC, Fu PP. Gene expression profiling as an initial approach for
mechanistic studies of toxicity and tumorigenicity of herbal plants and herbal dietary supplements. J Environ Sci
Health C Environ Carcinog Ecotoxicol Rev. 2010;28:60–87. [PMC free article] [PubMed] [Google Scholar]

[38] Rabe C, Musch A, Schirmacher P, Kruis W, Hoffmann R. Acute hepatitis induced by an Aloe vera
preparation: a case report. World J Gastroenterol. 2005;11:303–304. [PMC free article] [PubMed] [Google
Scholar]

[39] Kanat O, Ozet A, Ataergin S. Aloe vera-induced acute toxic hepatitis in a healthy young man. Eur J Intern
Med. 2006;17:589. [PubMed] [Google Scholar]

[40] Bottenberg MM, Wall GC, Harvey RL, Habib S. Oral aloe vera-induced hepatitis. Ann Pharmacother.
2007;41:1740–1743. [PubMed] [Google Scholar]

[41] Curciarello J, De Ortuzar S, Borzi S, Bosia D. Severe acute hepatitis associated with intake of Aloe vera tea.
Gastroenterol Hepatol. 2008;31:436–438. [PubMed] [Google Scholar]

[42] Yang HN, Kim DJ, Kim YM, Kim BH, Sohn KM, Choi MJ, Choi YH. Aloe-induced toxic hepatitis. J Korean
Med Sci. 2010;25:492–495. [PMC free article] [PubMed] [Google Scholar]

[43] Lee J, Lee MS, Nam KW. Acute toxic hepatitis caused by an aloe vera preparation in a young patient: a case
report with a literature review. Korean J Gastroenterol. 2014;64:54–58. [PubMed] [Google Scholar]

[44] ParkMK Park JH, Kim NY Shin YG, Choi YS Lee JG, Kim KH Lee SK. Analysis of 13 phenolic compounds
in aloe species by high performance liquid chromatography. Phytochemi Anal. 1998;9:186–191. [Google Scholar]

[45] Rebecca W, Kayser O, Hagels H, Zessin KH, Madundo M, Gamba N. The phytochemical profile and
identification of main phenolic compounds from the leaf exudate of Aloe secun- diflora by high-performance
liquid chromatography-mass spectroscopy. Phytochem Anal. 2003;14:83–86. [PubMed] [Google Scholar]

[46] Reynolds T Observations on the phytochemistry of the Aloe leaf-exudate compounds. Bot J Linn Soc.
1985;90:179–199. [Google Scholar]

[47] Saccu D, Bogoni P, Procida G. Aloe exudate: characterization by reversed phase HPLC and headspace GC-
MS. J Agric Food Chem. 2001;49:4526–4530. [PubMed] [Google Scholar]

[48] Lin JG, Chen GW, Li TM, Chouh ST, Tan TW, Chung JG. Aloe-emodin induces apoptosis in T24 human
bladder cancer cells through the p53 dependent apoptotic pathway. J Urol. 2006;175:343–347. [PubMed] [Google
Scholar]

[49] Chen HC, Hsieh WT, Chang WC, Chung JG. Aloe-emodin induced in vitro G2/M arrest of cell cycle in
human promyelocytic leukemia HL-60 cells. Food Chem Toxicol. 2004;42:1251–1257. [PubMed] [Google
Scholar]
[50] Lee HZ. Protein kinase C involvement in aloe-emodin- and emodin-induced apoptosis in lung carcinoma cell.
Br J Pharmacol. 2001;134:1093–1103. [PMC free article] [PubMed] [Google Scholar]

[51] Popadic D, Savic E, Ramic Z, Djordjevic V, Trajkovic V, Medenica L, Popadic S. Aloe-emodin inhibits
proliferation of adult human keratinocytes in vitro. J Cosmet Sci. 2012;63:297–302. [PubMed] [Google Scholar]

[52] Buenz EJ. Aloin induces apoptosis in Jurkat cells. Toxicol In Vitro. 2008;22:422–429. [PubMed] [Google
Scholar]

[53] Yimam M, Brownell L, Jia Q. In vivo safety evaluation of UP780, a standardized composition of aloe
chromone aloesin formulated with an Aloe vera inner leaf fillet. Regul Toxicol Pharmacol. 2014;69:390–397.
[PubMed] [Google Scholar]

[54] Brown JP, Dietrich PS, Brown RJ. Frameshift mutagenicity of certain naturally occurring phenolic
compounds in the ‘Salmonella/microsome’ test: Activation of anthraquinone and flavonol glycosides by gut
bacterial enzymes. Biochem Soc Trans. 1977;5:1489–1492. [PubMed] [Google Scholar]

[55] Westendorf J, Marquardt H, Poginsky B, Dominiak M, Schmidt J. Genotoxicity of naturally occurring

hydroxyanthraquinones. Mutat Res. 1990;240:1–12. [PubMed] [Google Scholar]

[56] Nesslany F, Simar-Meintieres S, Ficheux H, Marzin D. Aloe-emodin-induced DNA fragmentation in the

mouse in vivo comet assay. Mutat Res. 2009;678:13–19. [PubMed] [Google Scholar]

[57] Heidemann A, Volkner W, Mengs U. Genotoxicity of aloeemodin in vitro and in vivo. Mutat Res.
1996;367:123–133. [PubMed] [Google Scholar]

[58] Muller SO, Eckert I, Lutz WK, Stopper H. Genotoxicity of the laxative drug components emodin, aloe-
emodin and danthron in mammalian cells: topoisomerase II mediated? Mutat Res. 1996;371:165–173. [PubMed]
[Google Scholar]

[59] Mueller SO, Stopper H. Characterization of the genotoxicity of anthraquinones in mammalian cells. Biochim
Biophys Acta. 1999;1428:406–414. [PubMed] [Google Scholar]

[60] Li Y, Luan Y, Qi X, Li M, Gong L, Xue X, Wu X, Wu Y, Chen M, Xing G, Yao J, Ren J. Emodin triggers
DNA double-strand breaks by stabilizing topoisomerase II-DNA cleavage complexes and by inhibiting ATP
hydrolysis of topoisomerase II. Toxicol Sci. 2010;118:435–443. [PubMed] [Google Scholar]

[61] Lee HZ, Lin CJ, Yang WH, Leung WC, Chang SP. Aloe-emodin induced DNA damage through generation of
reactive oxygen species in human lung carcinoma cells. Cancer Lett. 2006;239:55–63. [PubMed] [Google Scholar]

[62] Chiang JH, Yang JS, Ma CY, Yang MD, Huang HY, Hsia TC, Kuo HM, Wu PP, Lee TH, Chung JG.
Danthron, an anthraquinone derivative, induces DNA damage and caspase cascades-mediated apoptosis in SNU-1
human gastric cancer cells through mitochondrial permeability transition pores and Bax-triggered pathways. Chem
Res Toxicol. 2011;24:20–29. [PubMed] [Google Scholar]

[63] Wolfle D, Schmutte C, Westendorf J, Marquardt H. Hydroxyanthraquinones as tumor promoters:

Enhancement of malignant transformation of C3H mouse fibroblasts and growth stimulation of primary rat
hepatocytes. Cancer Res. 1990;50:6540–6544. [PubMed] [Google Scholar]
[64] Mori H, Yoshimi N, Iwata H, Mori Y, Hara A, Tanaka T, Kawai K. Carcinogenicity of naturally occurring 1-
hydroxyanthraquinone in rats: Induction of large bowel, liver and stomach neoplasms. Carcinogenesis.
1990;11:799–802. [PubMed] [Google Scholar]

[65] National Toxicology Program. NTP Toxicology and Carcinogenesis Studies of emodiN (CAS NO. 518-82-1)
feed studies in F344/N rats and B6C3F1 mice. Natl Toxicol Program Tech Rep Ser. 2001;493:1–278. [PubMed]
[Google Scholar]

[66] Strickland FM, Muller HK, Stephens LC, Bucana CD, Donawho CK, Sun Y, Pelley RP. Induction of primary
cutaneous melanomas in C3H mice by combined treatment with ultraviolet radiation, ethanol and aloe emodin.
Photochem Photobiol. 2000;72:407–414. [PubMed] [Google Scholar]

[67] Fantus B Aloes as a medicine. J Am Pharm Assoc. 1922;11:616–619. [Google Scholar]

[68] van Gorkom BA, de Vries EG, Karrenbeld A, Kleibeuker JH. Review article: Anthranoid laxatives and their
potential carcinogenic effects. Aliment Pharmacol Ther. 1999;13:443–452. [PubMed] [Google Scholar]

[69] Cholongitas E, Katsoudas S, Dourakis S. Henoch-Schonlein purpura associated with Aloe vera
administration. Eur J Intern Med. 2005;16:59–60. [PubMed] [Google Scholar]

[70] Abendroth A, Klein R, Schlaak J, Metz KA, Dobos GJ, Langhorst J. Impressive picture of a melanosis coli
after chronic anthraquinone laxative use—Is there an increased risk for colorectal cancer? Z Gastroenterol
2009;47:579–582. [PubMed] [Google Scholar]

[71] Patel PM, Selby PJ, Deacon J, Chilvers C, McElwain TJ. Anthraquinone laxatives and human cancer: an
association in one case. Postgrad Med J. 1989;65:216–217. [PMC free article] [PubMed] [Google Scholar]

[72] Femenia A, Sánchez ES, Simal S, Rosselló C. Compositional features of polysaccharides from Aloe vera
(Aloe barbadensis Miller) plant tissues. Carbohydr Polymers. 1999;39:109–117. [Google Scholar]

[73] Hamman JH. Composition and applications of Aloe vera leaf gel. Molecules. 2008;13:1599–1616. [PMC free
article] [PubMed] [Google Scholar]

[74] Wang Y-T, Strong KJ. A two-year study monitoring several physical and chemical properties of field-grown
Aloe barbadensis Miller leaves. Subtropical Plant Sci. 1995;47:34–38. [Google Scholar]

[75] Tai-Nin Chow J, Williamson DA, Yates KM, Goux WJ. Chemical characterization of the immunomodulating
polysaccharide of Aloe vera L. Carbohydr Res. 2005;340:1131–1142. [PubMed] [Google Scholar]

[76] Mandal GD, Amalendu Structure of the glucomannan isolated from the leaves of Aloe barbadensis Miller.
Carbohydr Res. 1980;87:249–256. [Google Scholar]

[77] Yaron A Characterization of Aloe vera gel before and after autodegradation, and stabilization of the natural
fresh gel. Phytother Res. 1993;7:S11–S13. [Google Scholar]

[78] Avila H, Rivero J, Herrera F, Fraile G. Cytotoxicity of a low molecular weight fraction from Aloe vera (Aloe
barbadensis Miller) gel. Toxicon. 1997;35:1423–1430. [PubMed] [Google Scholar]
[79] Asgharzade S, Rafieian-Kopaei M, Mirzaeian A, Reiisi S and Salimzadeh L. Aloe vera toxic effects:
expression of inducible nitric oxide synthase (iNOS) in testis of Wistar rat. Iran J Basic Med Sci. 2015;38:967–
973. [PMC free article] [PubMed] [Google Scholar]

[80] Sehgal I, Winters WD, Scott M, Kousoulas K. An in vitro and in vivo toxicologic evaluation of a stabilized
aloe vera gel supplement drink in mice. Food Chem Toxicol. 2013;55:363–370. [PubMed] [Google Scholar]

[81] Herlihy JT, Bertrand HA, Kim JD, Ikeno Y, Yu BP. Effects of Aloe vera ingestion in the rat. I. Growth, food
and fluid intake and serum chemistry. Phytotherapy Res. 1998;12:183–188. [Google Scholar]

[82] Ikeno Y, Hubbard GB, Lee S, Yu BP, Herlihy JT. The influence of long-term Aloe vera ingestion on age-
related disease in male Fischer 344 rats. Phytother Res. 2002;16:712–718. [PubMed] [Google Scholar]

[83] Paes-Leme AA, Motta ES, De Mattos JC, Dantas FJ, Bezerra RJ, Caldeira-de-Araujo A. Assessment of Aloe
vera (L.) genotoxic potential on Escherichia coli and plasmid DNA. J Ethnopharmacol 2005;102:197–201.
[PubMed] [Google Scholar]

[84] Williams LD, Burdock GA, Shin E, Kim S, Jo TH, Jones KN, Matulka RA. Safety studies conducted on a
proprietary high-purity aloe vera inner leaf fillet preparation, Qmatrix. Regul Toxicol Pharmacol. 2010;57:90–98.
[PubMed] [Google Scholar]

[85] Visuthikosol V, Chowchuen B, Sukwanarat Y, Sriurairatana S, Boonpucknavig V. Effect of aloe vera gel to
healing of burn wound a clinical and histologic study. J Med Assoc Thai. 1995;78:403–409. [PubMed] [Google
Scholar]

[86] Reddy RL, Reddy RS, Ramesh T, Singh TR, Swapna LA, Laxmi NV. Randomized trial of aloe vera gel vs
triamcinolone acetonide ointment in the treatment of oral lichen planus. Quintessence Int. 2012;43:793–800.
[PubMed] [Google Scholar]

[87] Huseini HF, Kianbakht S, Hajiaghaee R, Dabaghian FH. Anti-hyperglycemic and anti- hypercholesterolemic
effects of Aloe vera leaf gel in hyperlipidemic type 2 diabetic patients: a randomized double-blind placebo-
controlled clinical trial. Planta Med. 2012;78:311–316. [PubMed] [Google Scholar]

[88] Babaee N, Zabihi E, Mohseni S, Moghadamnia AA. Evaluation of the therapeutic effects of Aloe vera gel on
minor recurrent aphthous stomatitis. Dent Res J (Isfahan). 2012;9:381–385. [PMC free article] [PubMed] [Google
Scholar]

[89] Morrow DM, Rapaport MJ, Strick RA. Hypersensitivity to aloe. Arch Dermatol. 1980;116:1064–1065.
[PubMed] [Google Scholar]

[90] Ferreira M, Teixeira M, Silva E, Selores M. Allergic contact dermatitis to Aloe vera. Contact Dermatitis.
2007;57:278–279. [PubMed] [Google Scholar]

[91] Hunter D, Frumkin A. Adverse reactions to vitamin E and aloe vera preparations after dermabrasion and
chemical peel. Cutis. 1991;47:193–196. [PubMed] [Google Scholar]
[92] Bailey RL, Gahche JJ, Lentino CV, Dwyer JT, Engel JS, Thomas PR, Betz JM, Sem- pos CT, Picciano MF.
Dietary supplement use in the United States, 2003-2006. J Nutr. 2011;141:261–266. [PMC free article] [PubMed]
[Google Scholar]

[93] Guo L, Fuscoe JC, Fu PP, Mei N. Application of DNA microarray in studies of herbal dietary supplements In:
Casciano DA, Sahu SC, eds., Handbook of Systems Toxicology, John Wiley & Sons Ltd, Chichester,
UK;2011:407–418. [Google Scholar]

[94] Ceccaroli C, Pulliero A, Geretto M, Izzotti A. Molecular fingerprints of environmental carcinogens in human
cancer. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2015;33:188–228. [PubMed] [Google Scholar]

[95] Ning B, Su Z, Mei N, Hong H, Deng H, Shi L, Fuscoe JC, Tolleson WH. Toxicogenomics and cancer
susceptibility: advances with next-generation sequencing. J Environ Sci Health C Environ Carcinog Ecotoxicol
Rev. 2014;32:121–158. [PMC free article] [PubMed] [Google Scholar]

[96] Ruan J, Gao H, Li N, Xue J, Chen J, Ke C, Ye Y, Fu PP, Zheng J, Wang J, Lin G. Pyrrole-Protein Adducts
Darah-Biomarker dari Hati yang Diinduksi Alkaloid Pyrrolizidine Cedera pada Manusia . J Lingkungan Sci
Kesehatan C Lingkungan Karsinog Ekotoksikol Rev. 2015; 33 :404–421. [ PubMed ] [ Google Cendekia ]

[97] Goldberg DS, Forde KA, Carbonari DM, Lewis JD, Leidl KB, Reddy KR, Haynes K, Roy J, Sha D, Marks
AR, Schneider JL, Strom BL, Corley DA, Lo Re V 3rd, Perwakilan populasi kejadian gagal hati akut akibat obat
berdasarkan analisis sistem pelayanan kesehatan terpadu . Gastroenterologi . 2015; 148 :1353–1361. [ Artikel
gratis PMC ] [ PubMed ] [ Google Cendekia ]

[98] Owens C, Baergen R, Puckett D. Sumber online informasi produk herbal . Apakah J Med . 2014; 127 :109–
115. [ PubMed ] [ Google Cendekia ]

[99] Dentali S. Kualifikasi penting “Nondecolorized” untuk bahan studi lidah buaya NTP . Ilmu Toksikol . 2013;
133 :342. [ PubMed ] [ Google Cendekia ]